IntroductionASCO 2024 Head & Neck Cancer developments brought forth several groundbreaking studies in the field of head and neck cancer,…
Browsing: Head and Neck
Oropharyngeal Cancer, Hypopharyngeal Cancer, Laryngeal Cancer, Lip and Oral Cavity Cancer, Nasopharyngeal Cancer, Paranasai Sinus and Nasal Cavity Cancer, Salivary Gland Cancer, Squamous Cell Neck Cancer, Soft Tissue Sarcoma, Thyroid Cancer, News and Information
By: Loren Michel, MD Date: October 25, 2023 At the recent ESMO conference, Dr. Loren Michel presented the results of…
Shirin Attarian, MD addresses the escalating incidence of head and neck cancer and highlights that most cases, particularly oropharyngeal cancers,…
Presented By: Shirin Attarian, MD Date Aug 12, 2023 In the realm of oncology, Head and Neck Cancer stands as…
When discussing the myriad of cancers that affect humans, head and neck cancers, though slightly less talked about, remain a…
In the ever-evolving landscape of medical science, melanoma and Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)…
Dr. Kevin Harrington, Phd of the Royal Marsden Hospital, The Institute of Cancer Research, London, is the author of this…
Ann M. Gillenwater, MD – MD Anderson, Department of Head and Neck Surgery, Division of Surgery presents the First Safety…
Ari Rosenberg, MD – University of Chicago The DEPEND trial investigated the use of neoadjuvant nivolumab, paclitaxel, and carboplatin followed…
Glenn Hanna, MD – Dana-Farber The combination of BCA101 and pembrolizumab as first-line therapy in patients with recurrent, metastatic head…
Head and neck cancer, collectively termed Head and Neck Cancer (HNC), is a group of biologically similar cancers that start…
Dr. Jessica Geiger from Cleveland Clinic presented an abstract at ASCO 2023 highlighting the potential of Enfortumab vedotin as a…
Join us in an insightful interview with renowned oncologist Dr. Emrullah Yilmaz, MD, PhD, as he discusses the potential of…
Squamous Cell Cancer, also known as squamous cell carcinoma (SCC), is an uncontrolled growth of abnormal cells arising in the…
Molecule, RRx-001, has received fast track designation from the FDA. RRx-001 is a designer molecule with direct anti-inflammatory activity and…
iFrame is not supported! Molecule RRx-001 Receives Fast Track Designation From the FDA – EpicentRx By Tony Reid, MD, PhD,…
Head and Neck Cancer: Discussion on Endocrine Oncology Research Innovations – Moffitt Moffitt Cancer CenterHost: Caitlin McMullen, MD, Member,…
In this video series Dr. Kathryn Gold, Medical Oncologist, specialized in lung, head and neck, Professor, Department of Medicine, UC…
In this video series Dr. Kathryn Gold, Medical Oncologist, specialized in lung, head and neck, Professor, Department of Medicine, UC…
In this video series Dr. Kathryn Gold, Medical Oncologist, specialized in lung, head and neck, Professor, Department of Medicine, UC…
In this video series Dr. Kathryn Gold, Medical Oncologist, specialized in lung, head and neck, Professor, Department of Medicine, UC…
In this video series Dr. Kathryn Gold, Medical Oncologist, specialized in lung, head and neck, Professor, Department of Medicine, UC…
In this video series Dr. Kathryn Gold, Medical Oncologist, specialized in lung, head and neck, Professor, Department of Medicine, UC…
In this video series Dr. Kathryn Gold, Medical Oncologist specializing in lung, head and neck cancers, Professor with the Department…
El Dr. Jared Weiss se une a nosotros para analizar la importancia de las pruebas y el diagnóstico temprano en…
El Dr. Jared Weiss se une a nosotros para analizar la importancia de las pruebas y el diagnóstico temprano en…
El Dr. Jared Weiss se une a nosotros para analizar la importancia de las pruebas y el diagnóstico temprano en…
Dr. Jared Weiss joins us to discuss the importance of testing and early diagnosis in cancer care, with a concentration…
Dr. Jared Weiss joins us to discuss the importance of testing and early diagnosis in cancer care, with a concentration…
Dr. Jared Weiss joins us to discuss the importance of testing and early diagnosis in cancer care, with a concentration…
iFrame is not supported! Genomic-Adjusted Radiation Dose Explained [2022] What Is Genomic-Adjusted Radiation Dose (GARD)? Genomic-Adjusted Radiation Dose (GARD)…
Genomic-Adjusted Radiation Dose Explained [2022] What Is Genomic-Adjusted Radiation Dose (GARD)? Genomic-Adjusted Radiation Dose (GARD) is a mathematical formalism…
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Jared…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Jared…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Jared…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Jared…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell…
Umamaheswar Duvvuri, MD, Ph.D., FACS, Professor, Department of Otolaryngology at UPMC and the VA Pittsburg Health System. In this video,…
Umamaheswar Duvvuri, MD, Ph.D., FACS, Professor, Department of Otolaryngology at UPMC and the VA Pittsburg Health System. In this video,…
Philippe Spiess, MD from H. Lee Moffitt Cancer Center & Research Institute speaks about the ASCO 2021 Abstract – Clinically…
Eyal Talor, Ph.D., Chief Scientific Officer, Cel-Sci speaks about CEL-SCI’S Multikine® Immunotherapy Produces significant 14.1% 5-Year Survival Benefits (62.7% VS…
Philippe Spiess, MD from H. Lee Moffitt Cancer Center & Research Institute speaks about the ASCO 2021 Abstract – Clinically…
We are pleased to present this newest video series of updates from ASCO and ESMO 2020, with discussions on updates…
We are pleased to present this newest video series of updates from ASCO and ESMO 2020, with discussions on updates…
We are pleased to present this newest video series of updates from ASCO and ESMO 2020, with discussions on updates…
I think the field of cancer and in particular, head neck cancer has been. Somewhat revolutionized with the introduction of…
We are pleased to present this newest video series of updates from ASCO and ESMO 2020, with discussions on updates…
We are pleased to present this newest video series of updates from ASCO and ESMO 2020, with discussions on updates…
In this episode of The Onco’Zine Brief Peter Hofland talks with Peggy Berry, Vice president of Global Regulatory Affairs at…
Brianna Jones, MD, BS from the Icahn School of Medicine at Mount Sinai discusses ASTRO Abstract 3885 Pathologic Features and…
Barbara Burtness, MD of the Yale Cancer Center discusses the ASCO 2020 Abstract Correlation of tumor mutational burden (TMB) with…
Prof. Jean Bourhis, Department Head of Radio-Oncology at the University Hospital of Lausanne and Lead Investigator of Centre Hospitalier Universitaire…
J. Mel Sorensen, MD President, and Chief Executive Officer Galera Thereptutics, Inc gives an overview from ASCO 2020 abstract entitled…
Dan Paul Zandberg, MD at UPMC discusses an ASCO 2020 abstract entitled The impact of tumor hypoxia on the clinical…
Paz J. Vellanki, MD from U.S. Department of Health and Human Services discusses an ASCO 2020 abstract entitled Evaluation of…
Lillian Siu, MD Princess Margaret Cancer Centre discusses an ASCO 2020 abstract entitled Phase III LEAP-010 study: first-line pembrolizumab with…
Catherine Haring, MD & Paul Swiecicki, MD from University of Michigan Medical School discuss an ASCO 2020 abstract entitled HPV…
Ralph Zinner, MD University of Kentucky discusses an ASCO 2020 abstract entitled Neoadjuvant nivolumab (N) plus weekly carboplatin (C) and…
Michelle Echevarria, MD from Moffitt Cancer Center discusses an ASCO 2020 Phase I dose escalation of stereotactic body radiation therapy…
Kedar Kirtane, MD from Moffitt Cancer Center discusses an ASCO 2020 abstract entitled Concurrent cetuximab (CTX) and nivolumab (NIVO) in…
J. Silvio Gutkind, PhD – UC San Diego discusses Precision Medicine Identifies Key Recurring Mutation in Head and Neck Cancers…
J. Silvio Gutkind, PhD – UC San Diego discusses Precision Medicine Identifies Key Recurring Mutation in Head and Neck Cancers…
J. Silvio Gutkind, PhD – UC San Diego discusses Precision Medicine Identifies Key Recurring Mutation in Head and Neck Cancers…
J. Silvio Gutkind, PhD – UC San Diego discusses Verastem Oncology Announces Presentation of Preclinical Data Supporting the Combination of…
J. Silvio Gutkind, PhD – UC San Diego discusses Verastem Oncology Announces Presentation of Preclinical Data Supporting the Combination of…
J. Silvio Gutkind, PhD – UC San Diego discusses Verastem Oncology Announces Presentation of Preclinical Data Supporting the Combination of…
Erminia Massarelli, MD City of Hope discusses INDUCE-1: Report on safety run-in cohorts combining Inducible T-cell co-stimulatory receptor (ICOS) agonist…
Erminia Massarelli, MD City of Hope discusses INDUCE-1: Report on safety run-in cohorts combining Inducible T-cell co-stimulatory receptor (ICOS) agonist…
Erminia Massarelli, MD City of Hope discusses INDUCE-1: Report on safety run-in cohorts combining Inducible T-cell co-stimulatory receptor (ICOS) agonist…
Michael Gerard McCusker, MD – University of Maryland Medical Systems discusses Cisplatin every three weeks versus weekly cisplatin or carboplatin…
Michael Gerard McCusker, MD – University of Maryland Medical Systems discusses Cisplatin every three weeks versus weekly cisplatin or carboplatin…
Michael Gerard McCusker, MD – University of Maryland Medical Systems discusses Cisplatin every three weeks versus weekly cisplatin or carboplatin…
Miguel Garcia-Guzman, PH.D., Vice Chairman, Chief Scientific Officer, Rakuten Medical discusses Rakuten Medical Presents Data during AACR Characterizing how Illuminox…
Miguel Garcia-Guzman, PH.D., Vice Chairman, Chief Scientific Officer, Rakuten Medical discusses Rakuten Medical Presents Data during AACR Characterizing how Illuminox…
Miguel Garcia-Guzman, PH.D., Vice Chairman, Chief Scientific Officer, Rakuten Medical discusses Rakuten Medical Presents Data during AACR Characterizing how Illuminox…
Miguel Garcia-Guzman, PH.D., Vice Chairman, Chief Scientific Officer, Rakuten Medical discusses Rakuten Medical Presents Data during AACR Characterizing how Illuminox…
Total glossectomy is a surgical option for patients with advanced (stage IV cancers) or recurrent tongue cancer. Advanced cancer of…
Buccal cancer involving masticator space grows rapidly and penetrates well with a high recurrence rate due its aggressive nature. The…
Kevin Harrington, PhD, MBBS, of the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust discusses KEYNOTE-048: progression…
Kevin Harrington, PhD, MBBS, of the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust discusses KEYNOTE-048: progression…
Kevin Harrington, PhD, MBBS, of the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust discusses KEYNOTE-048: progression…
Cherie-Ann O. Nathan, MD of LSU Health Shreveport @LSUHS @LSUHealthNO answers if this will affect clinicians and treatment for progression-free…
Cherie-Ann O. Nathan, MD of LSU Health Shreveport @LSUHS @LSUHealthNO answers what type of TP53 mutations benefited from this for…
Cherie-Ann O. Nathan, MD of LSU Health Shreveport @LSUHS @LSUHealthNO answers questions on immunotherapy for a drug used for breast…
Cherie-Ann O. Nathan, MD of LSU Health Shreveport @LSUHS @LSUHealthNO discusses a drug used for breast and kidney cancer may…
In Roswell Park study, 42% of patients who received gabapentin for pain managementrequired no narcotics Most patients treated for head…
Anurag Singh, MD of Roswell Park explains what’s next in research. ______ Roswell Park researchers present findings at ASTRO Annual…
Anurag Singh, MD of Roswell Park explains a commonly asked question by colleagues: why is there no benefit to cancer…
Anurag Singh, MD of Roswell Park reveals that patients with some cancers who have taken baby aspirin can improve overall…
Roswell Park researchers present findings at ASTRO Annual Meeting Aspirin improved overall survival for patients with head/neck, lung cancers Patients…
Danny Rischin, MD, Division of Cancer Medicine, Department of Medical Oncology, Peter MacCallum Cancer Centre, Professor of Medicine, University of…
Danny Rischin, MD, Division of Cancer Medicine, Department of Medical Oncology, Peter MacCallum Cancer Centre, Professor of Medicine, University of…
Danny Rischin, MD, Division of Cancer Medicine, Department of Medical Oncology, Peter MacCallum Cancer Centre, Professor of Medicine, University of…
Michael R. Migden, M.D., discusses locally advanced cutaneous squamous cell carcinoms. Background: Cemiplimab (REGN2810) produced substantial antitumor activity with durable…
Michael R. Migden, M.D., discusses the phase 2 results of Cemiplimab. Background: Cemiplimab (REGN2810) produced substantial antitumor activity with durable…
Danny Rischin MD Of Peter MacCallum Cancer Centre Discusses Who Should Get Monotherapy Or Pembrolizumab Combo: Reasonable To Use Pembrolizumab…
Danny Rischin MD Of Peter MacCallum Cancer Centre Discusses KEYNOTE-48 Trial: 882 Patients Were Enrolled In Under 2 Years, Primary…
Danny Rischin MD Of Peter MacCallum Cancer Centre Discusses KEYNOTE-48 Trial Implications: Will Provide An Opportunity For Patients To Have…
David Anderson PhD Of VBI Vaccines Discusses VBI-1901 Vaccine: Two Different Components In The Vaccine gB & pp65 Delivered In…
David Anderson PhD Of VBI Vaccines Discusses Early Stages Of VBI-1901 Vaccine: Demonstrate Safety First, Encouraged By Correlations, Need To…
David Anderson PhD Of VBI Vaccines Discusses Are CMV antigens There: Multiple Publications Demonstrated Using A Variety Of Techniques That…
David M. Cognetti MD @KimmelCancerCtr Of Sidney Kimmel Cancer Center Discusses Photoimmunotherapy (PIT) Phase 2 Study Results: 30 Patients With…
David M. Cognetti MD @KimmelCancerCtr Of Sidney Kimmel Cancer Center Discusses Photoimmunotherapy (PIT) Phase 3 Study: Opening Now To Compare…
David M. Cognetti MD @KimmelCancerCtr Of Sidney Kimmel Cancer Center Discusses Photoimmunotherapy (PIT): Superior To Photodynamic Therapy Due To The…
David M. Cognetti MD @KimmelCancerCtr Of Sidney Kimmel Cancer Center Discusses Photoimmunotherapy Technology: Very Straight forward From A Technical Standpoint,…
GRACE – Global Resource for Advancing Cancer Education Published on Jul 29, 2016 5th video in our series ASCO 2016…
Byoung Chul Cho, M.D., Yonsei Cancer Center discusses Efficacy & Safety Of M7824. At ESMO Oncology Conference – Munich, Germany…
Byoung Chul Cho, M.D., Yonsei Cancer Center discusses NSCLC With M7824 Second Line Therapy. At ESMO Oncology Conference – Munich,…
Byoung Chul Cho, M.D., Yonsei Cancer Center discusses What To Expect In NSCLC & HN Cancer For 2019. At ESMO…
In this video, recorded at the American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL, Susan Peterson,…
In this video, recorded at the American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL, Susan Peterson,…
Drs Jared Weiss and Joshua Bauml discuss advances in treatment for head and neck cancer from ASCO 2018.
Drs Jared Weiss and Joshua Bauml discuss advances in treatment for head and neck cancer from ASCO 2018.
Drs Jared Weiss and Joshua Bauml discuss advances in treatment for head and neck cancer from ASCO 2018.
Locally advanced head and neck cancer is treated with chemotherapy and radiation as standard, with an aim to cure the…
Cetuximab monotherapy is the standard of care for platinum-resistant non-HPV related metastatic head and neck cancer; however, response and survival…
Speaking from the American Society of Oncology (ASCO) 2018 Annual Meeting in Chicago, IL, Ezra Cohen, MD, FRCPC, FASCO, of…
Metastatic head and neck cancer that has progressed following platinum therapy generally has a very poor prognosis. In this video,…
Prognoses for patients with relapsed metastatic head and neck cancer that has progressed on prior platinum therapy are poor. Here,…
Kevin Harrington, PhD, MBBS, of the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, UK, presented…